Similar results have been obtained by Grassian et al. [38] showing that tumor cells expressing mutant IDH1 are more sensitive to pharmacologic inhibition of oxidative metabolism compared to IDH1 wildtype cells. This evidence concerns the gene IDH1 and neoplasm.